Abstract: A bisphosphonate is formulated with an agent to reduce surface tension and/or reduce foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
Type:
Grant
Filed:
October 31, 2008
Date of Patent:
January 10, 2012
Assignee:
Selamine Limited
Inventors:
Paul Jonathan Harrison, Anna Marie Power
Abstract: The present invention relates to an oral pharmaceutical formulation that employs: (1) a compressed core containing a decongestant or pharmaceutically acceptable salt thereof; (2) a delayed release coating on the compressed core and (3) immediate release therapeutic amounts of a decongestant and an antihistamine.
Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative and a disintegrating agent is herein disclosed and described. The dosage formulation exhibits a significant increase in bioavailability of the thiazolidinedione derivative component compared to conventional immediate release dosage forms containing only a thiazolidinedione derivative.
Abstract: A sterilizable particle-size reduction apparatus, component parts thereof and a method of sterilizing and validating sterility thereof are provided. Also provided is use thereof to prepare sterile suspensions of drugs.
Type:
Grant
Filed:
September 23, 2010
Date of Patent:
November 8, 2011
Assignee:
Resolution Chemicals Limited
Inventors:
Alan K. Greenwood, Derek McHattie, Parveen Bhatarah, Gary Hembra
Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a angiotensin antagonist is herein disclosed and described.
Abstract: A medicament dispenser comprises a housing having opposing first and second walls. A connecting assembly is associated with at least one of the first and second walls to facilitate connection of the first and second walls to one another. A blister pack containing the medicament is pivotally connected to the connecting assembly so as to be rotatable about the connecting assembly and about an axis of rotation substantially orthogonal to the first and second walls to facilitate movement of the blister pack from: i) a closed position in which the blister pack is substantially enclosed within the housing; and ii) an open position in which the blister pack is at least partially rotated from the housing.
Abstract: A pharmaceutical composition that contains an atypical antipsychotic drug and succinic acid, fumaric acid or a mixture of succinic acid and fumaric acid.
Abstract: An in-floor receptacle or electrical conduit box with a compartment divider removably attached to a gang-plate divider, a gang-plate divider removably attached to a gang-unit holder, at least one gang-unit holder removably attached to the inside of the box, and at least one knockout located on each side or floor of the box. The in-floor electrical conduit box enables the connection of permanent cables, wires or cords to temporary cables, wires or cords. The in-floor electrical conduit box further comprises a lid with at least one removable door whereby the removal of the door permits cable access to the box while the box is still covered.
Abstract: A system and method for generating, transmitting and distributing audio signals. The system and method may include an array having a plurality of microphones and a plurality of speakers as well as a first processor disposed proximate the array. The system and method can also have a second processor disposed remotely from the array and communicatively coupled with the array, at least one remotely located device having at least one microphone and at least one speaker and one or more remotely located speakers. Also, there may be an audio signal that is generated by one of a microphone on the array and a microphone on the at least one remotely located device, the location of the generation of the audio signal determined by one of the first processor and the second processor, generated audio signal transmitted to at least one of the speakers on the array, the at least one speaker on the remotely located device and the one or more remotely located speakers.
Abstract: A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
Abstract: A divisible pharmaceutical tablet comprises an upper portion and a lower portion, the upper portion including at least one upper convex surface bordering at least one dividing notch. A ridgeline is formed between the at least one dividing notch and the at least one upper convex surface. The upper convex surface includes an apex defined at a location along the ridgeline.
Type:
Grant
Filed:
December 22, 2006
Date of Patent:
July 26, 2011
Assignee:
Watson Laboratories, Inc.
Inventors:
Nilesh H. Parikh, William Crawford Hite, Bhavesh R. Patel
Abstract: A camera manipulation device comprising a plate having a top surface, a mounting element for securing a camera to the top surface of the plate, a handle for a user to hold the camera manipulation device and two or more connector elements for connecting the handle to the mounting plate, wherein each of said connector elements comprises at least one of a first and second pivot element.
Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
Type:
Grant
Filed:
February 12, 2004
Date of Patent:
June 14, 2011
Assignee:
Watson Pharmaceuticals, Inc.
Inventors:
Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia